← Amneal Pharmaceuticals, Inc.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $213.4m | $151.2m | $341.4m | $247.8m | $26.0m | $91.5m | $110.6m | $282.0m | |
| Receivables | $481.5m | $604.4m | $638.9m | $662.6m | $741.8m | $614.7m | $776.2m | $895.6m | |
| Inventories | $457.2m | $381.1m | $490.6m | $489.4m | $530.7m | $581.4m | $612.5m | $606.3m | |
| Prepaid expenses and other current assets | $128.3m | $70.2m | $73.5m | $110.2m | $103.6m | $82.7m | $80.7m | $98.4m | |
| Total current assets | $1.3b | $1.2b | $1.6b | $1.5b | $1.4b | $1.4b | $1.6b | $1.9b | |
| Property, plant and equipment, net | $544.1m | $478.0m | $477.8m | $514.2m | $469.8m | $447.6m | $424.9m | $442.9m | |
| Goodwill | $426.2m | $419.5m | $522.8m | $593.0m | $598.9m | $598.6m | $597.4m | $595.5m | |
| Intangible assets, net | $1.7b | $1.4b | $1.3b | $1.2b | $1.1b | $890.4m | $732.4m | $563.5m | |
| Operating lease right-of-use assets | $0 | $69.9m | $58.7m | $60.4m | $56.1m | $43.3m | $42.4m | $54.0m | |
| Financing lease right of use assets | $0 | $61.3m | $58.7m | $64.5m | $63.4m | $59.3m | $56.4m | $53.3m | |
| Other assets | $67.6m | $44.3m | $31.9m | $20.6m | $103.2m | $55.5m | $60.1m | $57.8m | |
| Restricted cash | $5.4m | $1.6m | $5.7m | $8.9m | $9.3m | $7.6m | $7.9m | $28.8m | |
| Payable | $514.4m | $507.5m | $613.7m | $583.3m | $538.2m | $542.0m | $757.8m | $816.8m | |
| Current portion of liabilities for legal matters | — | — | — | $58.0m | $107.5m | $77.0m | $31.8m | $43.3m | |
| Revolving credit facility | — | — | — | $0 | $60.0m | $179.0m | $100.0m | $0 | |
| Current portion of operating lease liabilities | $0 | $14.4m | $9.3m | $12.3m | $11.2m | $12.0m | $12.8m | $11.4m | |
| Current portion of financing lease liabilities | — | — | $3.0m | $3.1m | $3.5m | $2.5m | $3.2m | $3.4m | |
| Operating lease liabilities | $0 | $58.6m | $53.2m | $51.7m | $48.0m | $36.9m | $34.2m | $47.4m | |
| Financing lease liabilities | $0 | $61.5m | $60.2m | $60.3m | $60.8m | $58.6m | $56.9m | $54.9m | |
| Liabilities for legal matters - long term | — | — | — | — | — | $316k | $85.5m | $71.8m | |
| Redeemable non-controlling interests | — | $0 | $11.8m | $16.9m | $24.9m | $41.3m | $65.0m | $77.3m | |
| Non-controlling interests | $391.6m | $114.8m | $41.7m | $6.6m | ($114.4m) | $230k | ($245k) | ($535k) | |
| Total long-term liabilities | $2.9b | $2.8b | $3.0b | $2.9b | $2.8b | $2.6b | $2.4b | $2.8b | |
| Total Amneal Pharmaceuticals, Inc. stockholders’ deficiency | $504.8m | $232.0m | $303.3m | $360.3m | $298.4m | $19.8m | ($109.3m) | ($70.8m) | |
| Total stockholders’ deficiency | $896.4m | $346.8m | $344.9m | $367.0m | $184.0m | $20.0m | ($109.5m) | ($71.3m) | |
| Total assets | $4.4b | $3.7b | $4.0b | $3.9b | $3.8b | $3.5b | $3.5b | $3.7b | |
| Total liabilities and stockholders’ deficiency | $4.4b | $3.7b | $4.0b | $3.9b | $3.8b | $3.5b | $3.5b | $3.7b | |
| Current portion of long-term debt, net | $21.4m | $21.5m | $44.2m | $30.6m | $30.0m | $34.1m | $224.2m | $6.8m | |
| Total current liabilities | $553.9m | $550.4m | $676.9m | $677.2m | $752.8m | $846.6m | $1.1b | $881.6m | |
| Long-term debt, net | $2.6b | $2.6b | $2.7b | $2.7b | $2.6b | $2.4b | $2.2b | $2.6b | |
| Other long-term liabilities | $38.8m | $39.6m | $85.7m | $38.9m | $87.5m | $41.8m | $77.8m | $51.4m | |
| Commitments and contingencies (Notes 4, 19 and 22) | $0 | $0 | — | — | — | — | — | — | |
| Preferred stock, $0.01 par value, 2,000 shares authorized at December 31, 2025 and 2024; none issued at both December 31, 2025 and 2024 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Common stock | $3.0m | $3.0m | $3.0m | $3.0m | $3.0m | $3.1m | $3.1m | $3.1m | |
| Additional paid-in capital | $530.4m | $607.0m | $628.4m | $658.4m | $691.6m | $539.2m | $560.2m | $571.8m | |
| Stockholders’ accumulated deficit | ($20.9m) | ($377.9m) | ($286.8m) | ($276.2m) | ($406.2m) | ($490.2m) | ($607.1m) | ($535.0m) | |
| Accumulated other comprehensive loss | ($7.8m) | ($68k) | ($41.3m) | ($24.8m) | $9.9m | ($32.3m) | ($65.5m) | ($110.7m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.